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Fanconi anemia (FA) is a rare genetic disease characterized by an increased risk for 
bone marrow failure, leukemia, and premature cancers (Alter et al., 2018). The FA 
pathway is involved in the repair of DNA damage such as stalled replication forks and 
DNA interstrand crosslinks (ICL) (Feng et al., 2019; Schlacher et al., 2012). It has 
been previously seen that under conditions of replication stress, FANCD2, a key 
protein in the FA pathway, binds to and traverses large actively transcribed genes 
(Okamoto et al., 2018). Using U2OS 3xFLAG cells we seek to answer the question of 
why FANCD2 is binding to these genes and if by doing so is it acting as a regulator of 
transcription? To answer this question, we used a candidate gene approach and chose 
WWOX and SOX5 and observed if under conditions of aphidicolin (APH), there were 
changes in their protein and transcript levels. We also observed if the absence of 
FANCD2 would affect their protein and transcript levels. In this study, it was found 
that under conditions of replication stress there was little change in both the protein 
and transcript levels of SOX5 and WWOX. Interestingly, the analysis of an RNA 
sequencing experiment brought to light the potential for FANCD2 to be involved in 
neuronal development as it was found that there were significant differences in 
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Fanconi anemia (FA) is a rare genetic disorder that can lead to bone marrow failure, 
leukemia, and premature cancers (Alter et al., 2018). The median age of onset of FA is 
seven years but patients may exhibit symptomatic and asymptomatic disease from 
birth to the age of fifty (Fiesco-Roa et al., 2019). Biallelic mutations in one of the 
twenty-three FA genes that encode for proteins can lead to FA diagnosis (Fiesco-Roa 
et al., 2019). FA results from biallelic mutations in any one of the following genes: 
FANCA, FANCB, FANCC, BRCA2 (FANCD1), FANCD2, FANCE, FANCF, FANCG, 
FANCI, BRIP1 (FANCJ), FANCL, FANCM, PALB2 (FANCN), RAD51C (FANCO), 
SLX4 (FANCP), ERCC4 (FANCQ), RAD51 (FANCR), BRCA1 (FANCS), UBE2T 
(FANCT), XRCC2 (FANCU), MAD2L2 (FANCV), RFWD3 (FANCW) (Milletti et al., 
2020). Patients with FA have an increased chance of developing acute myelogenous 
leukemia and squamous cell carcinomas of the head and neck in comparison to the 
non-FA population (Scheckenback et al., 2012; Fiesco-Roa et al., 2019). Clinical 
characteristics of patients with FA include physical abnormalities such as short stature, 
microcephaly, and abnormal skin pigmentation as well as an overall increased chance 
of developing cancers (Hays et al., 2014). It is important to note that FA patients 
should be further subtyped as there is clinical variability amongst the subtypes. 
 The FA genes are autosomal recessive apart from FANCB which is X-linked, 




repair pathway which is associated with the mending of DNA interstrand crosslinks 
(ICL) and stabilization of stalled replication forks (Fig. 1) (Feng et al., 2019; 
Schlacher et al., 2012). The elimination of DNA damage is necessary for the 
maintenance of genomic integrity. Inefficient repair of DNA damage can lead to 
genomic instability increasing the likelihood of cancer commencement and 
development (Niraj et al., 2019). The common diagnostic test for establishing if 
someone has FA is by determining if there is cellular hypersensitivity to DNA 
interstrand crosslinking agents (ICLs) such as mitomycin C (MMC). The exposure of 
FA cells to this agent results in increased levels of chromosomal aberrations, including 
chromosomal breaks and radial formations, as well as an increase in cell cycle arrest at 
the G2/M phase (Kee & D’Andrea, 2012).  
 The FA protein network can be further divided into groups based on 
commonalities in function. FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, 
FANCL, and FANCM function as the FA core complex and together with the E2 
ubiquitin-conjugating enzyme FANCT/UBE2T, monoubiquitinate FANCD2 and 
FANCI. FANCL, FANCB, and FAAP100 can also form a sub-catalytic complex that 
is able to support low levels of monoubiquitination, while FANCA-FANCG-FAAP20 
and FANCC-FANCE-FANCF provide support for the chromatin and DNA damage 
associated with the catalytic module (Huang et al., 2014). Mutations in any one of the 
eight proteins in the core complex results in loss of function in the FANCD2/FANCI 
monoubiquitination (Kee & D’Andrea, 2012). FANCI and FANCD2 are paralogs and 















































e Further downstream 
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repair by homologous 
recombination
Figure 1. Identification and coordination of FA pathway in ICL 
repair. a,b. Replication forks stall at DNA ICLs and recognized by 
FANCM-FAAP24-MHF1-MFH2 (FAAPs) or UHRF1. Helicase 
removed by BRCA1 allowing one of the replication forks to converge 
on the ICL. c. FANCM further assists in the initiation of the ATR-kinase 
dependent checkpoint. d. FA core complex monoubiquitinates FANCI-
FANCD2 (ID2) complex. e. FANCD2 recruit’s endonuclease to ICL site 
to induce DSB to further be repaired by homologous recombination 




  Recently, Tan et al., 2020 discovered that the monoubiquitination of ID2 
promotes protein:protein interaction and helps to stabilize the ID2 heterodimer onto 
the double stranded DNA (dsDNA). This clamping action has also been seen to only 
require the monoubiquitination of FANCD2 but not the dimer (Tan et al., 2020). The 
monoubiquitination of ID2 promotes the assembly of foci at sites of DNA damage in 
chromatin to further facilitate DNA repair and protect the genome. FANCI along with 
the core complex are required to produce FANCD2 foci that mark locations of DNA 
double-stranded breaks (DSBs), stalled replication forks, and R-loops in the nucleus in 
order to protect nascent DNA from degradation by nucleases (Taniguchi et al., 2002; 
Schwab et al., 2015). Following the exposure of DNA to damaging agents, and during 
S-phase of the cell cycle, the core complex will monoubiquitinate FANCD2 at lysine 
561 to signal the activation and translocation to nuclear foci (Garcia-Higuera et al., 
2001).  
 Post monoubiquitination, there is a recruitment of effectors that cleave the 
DNA including FANCQ (XPF) and FANCP (SLX4) (Y. Kim et al., 2011; Stoepker et 
al., 2011). FANCM-FAAP24-MHF also form a complex which acts upstream of the 
FA pathway to detect DNA damage as well as initiate signal transduction pathways to 
promote the monoubiquitination (Nepal et al., 2017). The monoubiquitination leads 
the BRCA2 protein into chromatin complexes to facilitate the assembly of DNA 
damage inducible RAD51 nuclear foci (Taniguchi et al., 2002; Schwab et al., 2015). 
FANCD2 will also oversee the coordination of ICL incision by SLX4-XPF or FAN1 
nuclease leading to repair by homologous recombination (H. Kim & D’Andrea, 2012). 




some DNA damage inducer resistance, how FANCD2 does this as well as responds to 
DNA replication stress is not fully understood. 
 The replication of the human genome is an intricate process that requires the 
organized activation and maintenance of replication forks ensuing from many sites of 
origins of replication during S-phase (Schwab et al., 2015). Precise DNA replication 
requires numerous factors, including proteins of the FA pathway. The accurate 
duplication of chromosomes, followed by their even segregation during mitosis is 
essential for genome stability (Mankouri et al., 2013). Errors that can occur during 
replication can impact the precise copying of chromosomes and segregation during 
mitosis. Replication stress is therefore, one of the main sources of genome instability. 
Sources of replication stress result from both endogenous as well as exogenous 
sources and can act either locally or globally. Sources can be categorized into 
alternations of origins firing, impediments to fork progression, conflicts between the 
DNA replication and transcription machineries, and DNA replication in unfit 
metabolic conditions (Magdalou et al., 2014).  
 Collapsed replication forks are a frequent contributor to spontaneous 
recombination events and genomic instability, both of which are hallmarks of cancer. 
DNA replication originates at thousands of individual replication origins that form 
bidirectional replication forks. Prior to S-phase, every origin is prepped by 
combinations of replication initiation proteins to ready the chromatin for replication 
(Barlow et al., 2013). After commencing, cells need to achieve balance, accuracy, 
speed, as well as the utilization and administration of necessary resources for example 




Therefore, eukaryotic cells initiate replication origins intermittently, dividing them 
into early replicating and late-replicating origins (Zeman & Cimprich., 2014). 
 DNA replication must also work through parts of the genome that are 
considered as more difficult to replicate because of an increased probability of breaks 
and gaps. Regions of the genome known as common fragile sites (CFSs) are more 
prone to breaks and gaps on metaphase chromosomes likely because of an increase of 
stalled replication forks at these regions (Debatisse et al., 2012). These regions require 
the replication fork to progress through CFSs, which causes a reliance on fork-restart 
mechanisms (Magdalou et al., 2014). When the DNA polymerase has stalled, helicases 
are continuing to unwind DNA resulting in an accumulation of single stranded DNA 
(ssDNA) at stalled forks. ssDNA is more unstable and more prone to be acted upon by 
nucleases (Byun et al., 2005). 
 During replication stress, regions containing CFSs have paused replication 
forks and consequently the forks are either at a standstill or moving slower as they 
move from flanking regions through CFSs to complete replication. This results in the 
inevitable collision of replication and transcription machineries intensifying genome 
instability (Debatisse et al., 2012). One result of this collision is the formation of R-
loops, which are DNA: RNA hybrids, that result from the nascent transcript 
reannealing to the corresponding template DNA strand causing the non-template 
strand to be displaced as ssDNA (Hamperl & Cimprich, 2016). These hybrids can lead 
to DNA damage because of the exposure of the ssDNA (Sollier & Cimprich, 2015). 




cell cycle, consequentially resulting in replication-transcription collisions resulting in 
potential R-loop formations (Hamperl & Cimprich, 2016). 
 Replication-transcription conflicts are often inevitable as there are many large 
genes in the genome requiring start-restart replication as well as more than one cell 
cycle for transcription (Helmrich et al., 2011). Conflicts are unavoidable in the longer 
human genes because these genes often overlap with CFSs resulting in longer times 
for transcription. Genes overlapping with CFSs are also replicated late in S-phase and 
are hotspots for chromosome instability (Le Tallec et al., 2014). This frequent 
association seen between large genes and transcriptional fragility, suggests a 
functional relationship, however the mechanisms underlying this association are not 
fully understood (Le Tallec et al., 2014) Collisions of the two systems can as 
previously stated result in R-loop formations but can also result from cis structural 
features such as DNA supercoiling, CFSs, and G-quadruplexes (Fig. 2) (García-Muse 
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Figure 2. The FA pathway and replication stress. While undergoing 
replication stress, the ATR checkpoint kinase is activated resulting in the 
monoubiquitination of the FANCD2-FANCI complex by the FA core E3 
ligase complex. This causes the replication machinery to be put under 
pressure and collide with concurrent transcription complex causing 
transcripts to enter the DNA helix and create R-loops. FANCD2 is 
recruited to sites of R-loops however, how it is recruited is still unknown 




 As DNA replication continues, it exposes ssDNA because of lagging strand 
synthesis. These ssDNA are more prone to fold into G-quadruplexes and impede 
replication fork progression. G-quadruplexes form due to the repetitive nature of the 
genome and can result in genomic instability (Hänsel-Hertsch et al., 2017). They are 
non-canonical DNA secondary structures that form because of the interactions of 
guanines in G-rich sequences where the nucleotides have interacted by Hoogsteen 
hydrogen bond that have been stabilized by a cation (Maffia et al., 2020). 
 A frequent hindrance of replication is caused when the replication fork 
encounters CFSs. These regions have been seen to undergo chromosomal 
rearrangements in tumors but the correlation between their role in cancer and 
implementation in replication has only recently been uncovered (Maffia et al., 2020). 
Studies have seen that these regions in the genome are sensitive to replication stress 
and the treatment of cells with aphidicolin, a DNA polymerase inhibitor, can cause 
breaks in metaphase chromosomes (Glover et al., 2017; Helmrich et al., 2011). When 
replication forks are confronted with obstacles during S phase, normally dormant 
replication origins are fired to prevent or rescue the instability. These CFS regions can 
be large with some being greater than 1 Mb in length as seen in a recent study 
identifying FANCD2 accumulating at large transcriptionally active genes (Okamoto et 
al., 2018). The Okamoto study found that FANCD2 preferentially bound to sites that 
were enriched near the center of the genic region of the large genes. Large genes can 
have a greater distance between dormant origins, increasing the likelihood of 




of the short supply of origins, the ability to activate this rescue mechanism is lost 
(Shima & Pederson, 2017).  
 Recent studies have investigated if there is a connection between FANCD2 and 
CFSs. One study has found that FANCD2 has been shown to reposition to large genes 
that comprise CFSs after replication stress (Fernandes et al., 2021). It has also been 
seen that FANCD2 forms foci at CFSs during mitosis, marking these areas as 
damaged (Chan et al., 2009). As a result of the FA pathway involvement in the 
coordination of replication and transcription by preventing or mending R-loops, a 
connection forms between the failure to resolve R-loops, CFS replication, and the 
genomic instability commonly seen in FA patients. In addition, a connection can be 
formed as FANCD2 has been seen to promote CFS replication by the regulation of R-
loop formation (Okamoto et al., 2019). It has also been previously seen that FANCD2 
may help promote the replication of CFSs (Madireddy et al., 2016). 
 Further recent discoveries involving FANCD2 include that FANCD2 has been 
seen to accumulate on large actively transcribed genes when under conditions of 
replication stress (Okamoto et al., 2018). A genome-wide chromatin localization of 
FANCD2 using chromatin immunoprecipitation sequencing (ChIP-seq) analysis was 
used to identify the binding footprints of FANCD2. This study found that FANCD2 
accumulates in the central region of large actively transcribed genes with some of the 
genes overlapping with known CFSs in cells that had been cultured in the presence of 
aphidicolin (Okamoto et al., 2018). This study also assembled a list of the top thirty 
genes of a total of 120, that FANCD2 was found to bind to under conditions of 




FANCD2 binding to these regions, and if by doing so it is preventing the transcription 
in these areas undergoing replication stress. 
 It has also been recently discovered that many of these large genes are prone to 
copy number variation (CNV) (Wilson et al., 2015). This is a type of mutation where 
the gene copy number can vary under certain conditions. Under replication stress, 
there could be a deletion of one allele and a triplication of the other allele causing the 
normal number of alleles to increase from two to three. At a locus that is more prone 
to CNV, there can be considerable variability in copy number and consequently in the 
levels of transcription of that gene (Wilson et al., 2015).  
 While there have been many studies of FANCD2 acting as part of the damage 
response, it has only recently come to light that this protein may have another function 
of acting as a transcriptional repressor for large actively transcribed genes that are 
undergoing replication stress. FANCD2 has been seen to bind to large 
transcriptionally active genes and that because of its role in DNA repair, it is binding 
to these regions because they are more susceptible to DNA damage. The question 
remains of what is FANCD2 doing when it binds to these large actively transcribed 
genes? Is it acting as a protector of the genome by blocking susceptible genes from 
being transcribed and causing DNA damage?  
 In this study, we used a candidate gene approach to test the hypothesis: if there 
are changes in gene expression at the sites that FANCD2 is found to bind to, then is 
FANCD2 impacting gene expression by binding to these regions? We focus on SOX5 
and WWOX in U2OS 3xFLAG cells to answer this question as these two genes encode 




broad FANCD2 peaks in the ChIP-seq data (Figs. 3 & 4). Aphidicolin, as previously 
stated is a DNA polymerase inhibitor and frequent inducer of replication stress. 
Through the utilization of aphidicolin as the replication stress inducer, we used 
immunoblotting as well as quantitative-PCR (qPCR) to analyze both the protein and 
transcript levels of SOX5 and WWOX. These two genes were chosen as SOX5, is a 
transcription factor involved in breast cancer regulation, and WWOX, a member of 
short-chain dehydrogenases and is found to span the common fragile site FRA16D 
(Driouch et al., 2002; Pei et al., 2014). They were also chosen because both proteins 
are intracellular making them good targets for immunoblotting using whole cell 
lysates. We first determined if there was a change in the protein and transcript levels 
under aphidicolin conditions and hypothesized that when FANCD2 is present and 
under conditions of replication stress, the amount of protein and transcript levels will 
decrease. We then used an siRNA to knock down FANCD2, aphidicolin as our 
replication stress inducer, and analyzed the consequences this had on both the protein 
and transcript levels and hypothesized that the levels will then increase in the absence 
of FANCD2.  
 We further analyzed the role FANCD2 may play under replication stress 
conditions by using ACHT hTERT cells both with and without FANCD2 and both 
with and without aphidicolin treatment for RNA sequencing. ACHT hTERT cells are a 
telomerase immortalized primary fibroblast patient cell line. ACHT hTERT FANCG 
(FANCD2 -/-) lack FANCD2 and ACHT hTERT FANCD2 have FANCD2 
complemented back into the line (ACHT hTERT +FANCD2). A patient cell line was 




more similar to an FA patient with a mutation in FANCD2 as opposed to a 
transformed cell line (U2OS 3xFLAG). This experiment allowed us to view the 
overall transcriptome to reveal not only if there are a greater number of genes affected 























Table 1. Okamoto et al., 2018 ChIP-seq top 30 hits of FANCD2 overlap. List of 
top 30 genes that FANCD2 was found to bind to, the chromosome location of the 
gene, if the location coincides with a known CFS, and the number of reads under 





Gene CFS Number of 
reads 
1 10q23 NRG3* - 8608 
2 16q23 WWOX FRA16D 7929 
3 16q23 CDH13* - 4704 
4 9p21 LINGO2* FRA9C 3832 
5 7p22 SDK1* FRA7B 3395 
6 11q14 DLG2* FRA11F 3302 
7 3p14 FHIT* FRA3B 3082 
8 3q11 EPHA6* - 3074 
9 3p26 CNTN4* - 2906 
10 12p12 SOX5 - 2241 
11 10q11 PRKG1 FRA10C 2091 
12 21p11 miR-3648 - 2002 
13 7q31 IMMP2L* FRA7K 1937 
14 21p11 miR-3687 - 1929 
15 5p14 CDH12* - 1800 
16 1p31 NEGR1* FRA1L 1392 
17 5p15 CTNND2* - 1072 
18 8q24.3 TRAPPC9* FRA8D 1001 
19 20p12 MACROD2* - 891 
20 4p15 - FRA4D 860 
21 1p36 - FRA1A 797 
22 11q13 - FRA11H 765 
23 7q11 MAGI2* - 636 
24 7q11 AUTS2* FRA7J 616 
25 13q33 FAM155A - 497 
26 4q35 FRG2 - 401 
27 9p32 ASTN2* - 380 
28 22q13 - FRA22A 346 
29 Xq22 DIAPH2 - 339 
30 2q22 THSD7B - 322 
 
Genes with (*) are related with autism, neurodevelopmental or psychiatric disorders. 
The number of ChIP-seq reads found in a gene or in a region that consist of a 


















Figure 3. FANCD2 displays broad peak over WWOX. ChIP-seq data 
from Okamoto et al., 2018 depicting FANCD2 accumulating in broad 
peaks over WWOX. U2OS 3xFLAG cells were treated with 0.4 µM 
aphidicolin (APH) for 24 hours. Anti-FLAG ChIP-seq reads depicting 
the WWOX gene region under no treatment (NT; yellow) or APH 
(orange) with peaks shown in blue. Image made using Integrated 
Genomics Viewer (IGV). Input samples are those have been crosslinked 















Figure 4. FANCD2 displays broad peak over SOX5. ChIP-seq data 
from Okamoto et al., 2018 depicting FANCD2 accumulating in broad 
peaks over SOX5. U2OS 3xFLAG cells were treated with 0.4 µM 
aphidicolin (APH) for 24 hours. Anti-FLAG ChIP-seq reads depicting 
the SOX5 gene region under no treatment (NT; yellow) or APH (orange) 
with peaks shown in blue. Image made using Integrated Genomics 
Viewer (IGV). Input samples are those have been crosslinked but not 









We received U2OS 3xFLAG cells created by Okamoto et al., 2018 that stably 
integrated a 3xFLAG on the 3’ end of the FANCD2 coding sequence. U2OS 3xFLAG 
cells are an osteosarcoma line and were grown in Dulbecco modified Eagle medium 
(DMEM) supplemented with 10% (vol/vol) fetal bovine serum, 1% (vol/vol L-
glutamine, and 1% (vol/vol) penicillin-streptomycin.  
 ACHT hTERT FANCD2 and ACHT hTERT FANCG (FANCD2-/-) cells 
received from Kalb et al., 2007, were grown in Dulbecco modified Eagle medium 
(DMEM) supplemented with 18% fetal bovine serum (vol/vol), 1% (vol/vol L-
glutamine, and 1% (vol/vol) penicillin-streptomycin. ACHT hTERT cells are human 
FA-D2 (FANCD2-/-) telomerase-immortalized skin fibroblast cells with one cell line 
having FANCD2 complemented into the cell. Mutations include: Allele 1 c.2444G>A 
(exon 26), r.2444G>A, p(R815Q), and Allele 2 c.2715+G>A, 
c.2715+1G>A (IVS28+1G>A), r.2715_2716ins27 (aberrant splicing), and 
p.(E906Lfs *4) (Kalb et al., 2007). 
 
Immunoblotting 
For immunoblotting analysis, cells were washed in phosphate-buffered saline (PBS) 
and lysed in 2% w/v SDS, 50 mM Tris-HCl, 10 mM EDTA followed by sonication for 




12% w/v Bis-Tris gels (Invitrogen) and transferred to polyvinylidene difluoride 
(PVDF) membranes. Antibodies and concentrations used are in Table 5. 
 
Replication Stress assay 
U2OS 3xFLAG cells were plated at 1 x 106 cells/mL and grown for 24 hours in 10 
cm2 dishes in a total of 8 mL DMEM media supplemented with 10% FBS, 1% (vol/vol 
L-glutamine, and 1% (vol/vol) penicillin-streptomycin. Cells were then treated with 
0.4 µM aphidicolin (APH) for 24 or 48 hours. One set of cells were then released from 
APH treatment and allowed to grow for an additional 24 hours. Cells were harvested 
24 hours after APH treatment, 48 hours after APH treatment, and 24 hours after 
release from APH treatment. ACHT hTERT FANCD2 and ACHT hTERT FANCG 
cells were also subjected to same experimental conditions. Cells were trypsinized 
using 0.05 % trypsin for 4 minutes. Media was then added to neutralize the trypsin and 
cells were spun down for 4 minutes to pellet in 15 mL centrifuge tubes. Media was 
then aspirated and cells were pelleted by centrifugation and resuspended in PBS 
 
siRNA 
U2OS 3xFLAG cells were plated at 1.75 x 105 cells per well in a 6 well plate and the 
following day treated with a 20 nM FANCD2 siRNA (target sequence: 
AACAGCCATGGATACACTTGA) or an siControl, and lipofectamine 2000 (Thermo 
Fisher) (Howlett et al., 2005). siControl is a random sequence that does not target a 
specific gene. siFANCD2 or siControl was left on for 24 hours, removed and allowed 




μM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release to induce 
replication stress. Cells were harvested 24 hours or 48 hours after APH treatment. The 
control for this experiment was a no treatment siControl in the presence and absence 
of APH. The siControl is used as it is an siRNA but does not target a specific gene. 
 
RNA Isolation 
U2OS 3xFLAG cells were grown in 10 cm2 dishes and treated using the replication 
stress assay as stated above. Cells were trypsinized using 0.05 % trypsin for 4 minutes. 
Media was then added to neutralize the trypsin and cells were spun down for 4 
minutes to pellet in 15 mL centrifuge tubes. Media was then aspirated and cells were 
pelleted by centrifugation and resuspended in PBS. Using the PureLink RNA Mini Kit 
(ThermoFisher) RNA was isolated, 80 µL/sample of a ~3 U/µL DNase treatment 
(ThermoFisher) was applied to the column provided in the PureLink RNA Mini Kit, 
and RNA was quantified using Nanodrop 2000 (ThermoFisher).  
 
cDNA Synthesis  
RNA was converted into single-stranded cDNA using the High-Capacity Reverse 
Transcription Kit (ThermoFisher). 1 µg of RNA was used from each sample. cDNA 
quantification was done using Nanodrop 2000 (ThermoFisher). 500 ng of cDNA was 








Abundance of SOX5 and WWOX transcripts were determined relative to GAPDH 
transcript abundance by qPCR. 5 µL PowerUp SYBR Green master mix 
(ThermoFisher) was used along with 4µL of 1.25 µM of primers designed by 
Integrated DNA Technologies (IDT) were used and Origene Technologies. Samples 
were run on the Roche LightCycler 480 at the URI Genomics and Sequencing Center. 
1 µL of a 500 ng stock of cDNA was used in the reaction. Data were analyzed via the 
2−ΔΔCT calculation method. Each reaction was run with initial denaturation at 95 ºC for 
5 minutes, followed by 45 cycles of denaturation at 95 ºC for 15 seconds, annealing at 
66 ºC for 15 seconds, and an extension of 1 minutes at 72 ºC. After completion of the 
last cycle, a melt curve analysis was performed according to the machine’s preset Step 
and Hold protocol (95 ºC for 5 seconds; 65 ºC for 1 minute; temperature ramp 
increment of 0.3 ºC up to 95 ºC). 
Primer Efficiency 
Primer efficiency qPCR was performed using 1500 ng, 150 ng, 15 ng, 1.5 ng, and 0.15 ng 
cDNA for GAPDH, WWOX, SOX5, and FANCD2. The same protocol as used for qPCR 
was used for the efficiency test with 1 µL of cDNA, 5 µL of PowerUp SYBR Green 
master mix, and 4 µL of the 1.25 µM stock primer. Primer efficiency was run for 2 
different sets of WWOX primers (WWOX 1 and WWOX 2), 2 different sets of SOX5 
primers (SOX5 1 and SOX5 2), and 3 different sets of FANCD2 primers (FANCD2 1, 






Primer Gradient  
Primer gradient PCR was performed using temperatures of 54.2, 55.2, 57.8, 59.5, 62.7, 
and 64.1 °C as well as 59.4, 62.4, 64.3, 66.2, 68.1, and 71 °C. Quantities of cDNA 
tested include 50 ng, 100 ng, 200 ng, 500 ng, and 1µg. Initial PCR reaction was the 
same as used for qPCR with 1 µL of the stock cDNA, 5 µL of PowerUp SYBR Green 
master mix, and 4 µL of the 1.25 µM stock primer. The PCR gradient was carried out on 
an Eppendorf vapo.protect Thermocycler with an initial denaturation of 94 ºC for 2 
minutes, followed by 40 cycles of denaturation for 5 seconds at 95 ºC, annealing at 
gradient temperatures (59.4, 62.4, 64.3, 66.2, 68.1, 71.0 °C), and an extension at 72 °C 
for 10 seconds.   
 PCR products were tested on a 2% agarose gel using 1x TBST and 10 µL SYBR 
SAFE DNA gel stain. 2 µL of 6x gel loading dye was added to the 10 µL reaction and the 
total 12 µL was loaded onto the gel. Agarose gel was run at 100 V for 50 minutes on a 
PowerEase 90W by Life Technologies. Gel was imaged using the Bio-Rad imager in the 
Howlett Lab.  
 
RNA-seq Analysis 
ACHT hTERT FANCD2 and ACHT hTERT FANCG (FANCD2-/-) cells were 
seeded, and the following day treated with 0.4 µM APH for 24 hours, 48 hours, and a 
no treatment sample in quadruplet. Cells were trypsinized using 0.25 % trypsin for 8 
minutes. Media was then added to neutralize the trypsin and cells were spun down for 
4 minutes to pellet in 15 mL centrifuge tubes. An ice-cold PBS wash was then applied, 




spun down in a microcentrifuge set to 4°C for 4 minutes. PBS was aspirated and cells 
were flash frozen using liquid nitrogen.  
 24 samples were sent to Genewiz in South Plainfield, NJ, USA. RNA library 
preparation with polyA selection and HiSeq Sequencing RNA library preparations was 
also completed at Genewiz. RNA samples were quantified using Qubit 2.0 
Fluorometer (Life Technologies, Carlsbad, CA, USA) and RNA integrity was checked 
using Agilent TapeStation 4200 (Agilent Technologies, Palo Alto, CA, USA). RNA 
sequencing libraries were then prepared using NEBNext Ultra II RNA Library Prep kit 
for Illumina using the manufacturer’s instructions (NEB, Ipswich, MA, USA). 
mRNAs were then initially enriched with Oligod(T) beads, and the enriched mRNAs 
were fragmented for 15 minutes at 94 °C. First and second strand cDNA was then 
subsequently synthesized, and the cDNA fragments were end repaired and adenylated 
at the 3’ ends. Universal adapters were ligated to cDNA fragments and followed with 
an index addition and library enrichment by PCR with limited cycles. The sequencing 
library was then validated on the Agilent TapeStation (Agilent Technologies, Palo 
Alto, CA, USA), and quantified by using Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, 
CA) as well as by quantitative PCR (KAPA Biosystems, Wilmington, MA, USA). The 
sequencing libraries were then clustered on a single lane of a flowcell and following 
clustering, the flowcell was loaded onto the Illumina HiSeq 4000 instrument according 
to manufacturer’s instructions. Samples were sequenced using a 2x150bp Paired End 
configuration at 60 million reads per sample. Image analysis and base calling were 
conducted using the HiSeq Control Software (HCS). The raw sequence data (.bcl files) 




de-multiplexed using Illumina’s bcl2fastq 2.17 software. One mismatch was allowed 
for index sequence identification. 
 
Bioinformatics Workflow 
 To analyze the quality of the raw data, the sequence reads were trimmed to 
remove possible adapter sequences as well as nucleotides with poor quality using 
Trimmomatic v.0.36. The quality threshold parameters under Trimmomatic were set at 
15 for the sliding window size of 4. Data quality ³ 80% of bases ³ Q30 were kept. The 
trimmed reads were then mapped to the most recent Homo sapiens reference genome 
that is available on ENSEMBL using the STAR aligner v.2.5.2b. STAR aligner is a 
splice aligner that can detect splice junctions and will incorporate them to help align 
the entire read sequences. BAM files were then generated, and unique gene hit counts 
were calculated by using FeatureCounts from the Subread package v.1.5.2. Only 
unique reads that fell within exon regions were counted. After the extraction of gene 
hit counts, the gene hit counts table was used for downstream differential expression 
analysis. DESeq2 was then used to compare gene expression between the groups of 
samples. The Wald test was then used to generate p-values and Log2foldchanges. 
Genes that had adjusted p-values were called as differentially expressed genes for each 
of the comparisons and a gene ontology analysis was performed on the statistically 
significant set of genes using the software GeneSCF. The goa_human GO list was 







To determine significance, either a single-factor ANOVA or two-factor ANOVA was 
used to test and post-hoc analysis was performed if significance was found. Student’s 
two-tailed paired t-test was also performed. P-value was determined using the 






















Table 2. Cell culture reagents used and catalog numbers. The following table 
includes a list of cell culture reagents and the company that they were purchased from. 
Product Name Source Catalog Number 
DMEM 1x ThermoFisher 11965118 
L-glutamine ThermoFisher 25030081 
 
Penicillin-streptomycin ThermoFisher 15070063 
 
PBS ThermoFisher 10010049 
 
0.05% Trypsin ThermoFisher 25300054 
 
0.25% Trypsin ThermoFisher 25200056 
 
FBS ThermoFisher 10437028 














Table 3. Immunoblotting reagents used and catalog numbers. The following table 
includes the reagents used for immunoblotting and the company they were purchased 
from. 
Product Name Source Catalog Number 
3-8% Tris-Acetate Gels ThermoFisher EA0378BOX 
4-12% Bis-Tris Gels ThermoFisher NP0335BOX 
NuPage Antioxidant ThermoFisher 17504044 


















Table 4. qPCR reagents used and catalog numbers. The following table includes a 
list of qPCR reagents and the company that they were purchased from. 
Product Name Source Catalog Number 
PureLink RNA Mini Kit ThermoFisher 12183018A 
SYBR Green ThermoFisher 4344463 
PureLink DNase ThermoFisher 12185-010 
cDNA ThermoFisher 4368814 
Gel Loading Purple Dye NEB B7025S 
Quick-load Purple 100 
bp DNA Ladder 
NEB N0551S 
SYBR Safe DNA gel 
stain 
ThermoFisher S33102 
Agarose ThermoFisher BP160-100 













Table 5. Antibodies, catalog numbers, and antibody working dilutions used in 
this study. The following table includes the antibodies used for immunoblotting as 
well as the company they were purchased from, and the dilution used. 
 
Product Name Source Catalog 
Number 
Dilution used 

















































Table 6. qPCR primer sequences, melting temperatures (Tm), and sequence 
lengths used in this study. The following table includes a list of the primer sequences 
used for qPCR as well as the melting temperatures, and sequence lengths. 
 















































60, 57  N/A 

















































Analysis of SOX5 and WWOX gene expression following aphidicolin treatment  
A previous study by Okamoto et al., 2018 utilized ChIP-seq and determined that under 
conditions of DNA replication stress, FANCD2 was found to bind and traverse large 
actively transcribed genes. However, it was not determined why FANCD2 was 
binding to these genes. To explore if FANCD2 could potentially be acting as a specific 
transcriptional repressor of these genes, we used a candidate gene approach to 
determine if there were changes in the expression of SOX5 and WWOX genes under 
conditions of replication stress. A candidate gene approach allowed us to choose two 
genes from the top 30 genes that FANCD2 was found to bind and do an in-depth 
analysis of WWOX and SOX5. 
  Cells were exposed to 0.4 µM APH and samples were run in triplicate and 
three biological samples were tested. RNA was purified from each sample and first-
strand cDNA was synthesized immediately after RNA isolation. Three separate qPCR 
reactions were assembled using the synthesized cDNA, representing three technical 
replicates. For each reaction GAPDH was used as the control housekeeping gene. 
Cycle threshold (Ct) values were averaged as well as the standard errors for the 
analysis. The Ct value is the cycle at which the fluorescence from the amplification 
exceeds the background fluorescence with each cycle ideally doubling the target 




Ranges of Ct values acceptable for analysis are less than 35 cycles while the 
recommended amounts of cDNA added to the reaction range from 5-50 ng of cDNA 
depending on the gene of interest as suggested by Thermo Scientific. Once normalized 
to GAPDH, the delta Ct values were also averaged for each timepoint. There was a 
decrease in gene expression for SOX5 between the no treatment sample and 24 hours 
of APH and 48 hours of APH (Fig. 5a). Gene expression then increased in the 24-hour 
release sample. While there were changes seen in gene expression, the changes were 
not significant. Standard error bars show the amount of variability within the samples 
between all replicates (Fig. 5a). 
 For WWOX, fold change analysis of the gene expression showed that there is a 
minor decrease in gene expression in the 24-hour and 48-hour samples in comparison 
to the no treatment, and an increase in the release sample but the difference is not 
significant (Fig. 5b). Bonferroni correction was applied by dividing 0.05 by the 









































































Figure 5. Analysis of SOX5 and WWOX gene expression in U2OS 
cells incubated in the absence or presence of aphidicolin (APH). 
U2OS cells were incubated in the absence (No Treatment) or presence of 
0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of 
release. Error bars represent the standard errors of the mean calculated 
from twenty-seven technical replicate measurements from three 
independent biological replicate experiments. Statistical significance 
was determined using student’s two-tailed paired t-test. *P < 0.001 and 
Single-Factor ANOVA. a. SOX5 gene expression. Bonferroni correction 




SOX5, WWOX, and GAPDH qPCR primer efficiency analysis 
Our results suggested little change in the levels of expression of SOX5 and WWOX 
under the conditions tested. Our Ct values for SOX5 and WWOX qPCR analysis also 
suggested that our qPCR conditions might not be optimal. Upon consulting with our 
colleagues and technical support at Thermo-Scientific, we decided to thoroughly 
analyze the efficiency of our qPCR primers using varying amounts of quantified 
cDNA input. Each gene had two sets of primers designed that were tested along with 
the housekeeping gene, GAPDH. To test the efficiency of the primers, a standard 
curve of cDNA was created using quantities of 1500 ng, 150 ng, 15 ng, 1.5 ng, and 
0.15 ng of cDNA.  
 Primers were run using the same protocol as our normal qPCR and standard 
curves were created for each primer set with each cDNA quantity run in duplicate. 
Analysis included observing the Ct values of the different quantities of cDNA and 
how similar amplification curves were between duplicates.  
 Figure 6 shows the amplification curves for GAPDH, SOX5, and WWOX. The 
amplification curves show that the duplicate samples are very consistent and as the 
quantity of cDNA decreases, the Ct value at which the amplification curve starts 
increases (Fig. 6, 7, 8). The GAPDH standard curve shows that duplicate samples are 
very close together and for all five quantities of cDNA, there was amplification. The 
Ct values for GAPDH range from 15 at 1500 ng of cDNA to 28 at 0.15 ng of cDNA 
(Fig. 6). The WWOX curve again had amplification for all five quantities of cDNA 
however, the number of cycles for amplification increased in comparison to the 




0.15 ng of cDNA (Fig. 7). For SOX5 there was no amplification for the 0.15 ng cDNA 
and the 15-ng amplified late at the 35th cycle the cycle limit for analysis. The Ct values 








































Figure 6. Analysis of GAPDH primer efficiency using a serial dilution 
of cDNA. qPCR was performed using either 1500 ng (blue lines), 150 ng 
(red lines), 15 ng (green lines), 1.5 ng (purple lines), or 0.15 ng (grey 
lines) with samples being run in duplicate. 1 µL of cDNA was added to 5 
µL of SYBR Green master mix, and 4 µL of a 1.25 µM stock primer. 
Amplification curves display how similar the duplicate samples are by 
how close together the same color curves are. As the amount of input 




















Figure 7. Analysis of WWOX2 primer efficiency using a serial 
dilution of cDNA. qPCR was performed using either 1500 ng (blue 
lines), 150 ng (red lines), 15 ng (green lines), 1.5 ng (purple lines), or 
0.15 ng (grey lines) with samples being run in duplicate. 1 µL of cDNA 
was added to 5 µL of SYBR Green master mix, and 4 µL of a 1.25 µM 
stock primer. Amplification curves display how similar the duplicate 
samples are by how close together the same color curves are. As the 




















Figure 8. Analysis of SOX52 primer efficiency using a serial dilution 
of cDNA. qPCR was performed using either 1500 ng (blue lines), 150 
ng (red lines), 15 ng (green lines), 1.5 ng (purple lines), or 0.15 ng (grey 
lines) with samples being run in duplicate. 1 µL of cDNA was added to 
5 µL of SYBR Green master mix, and 4 µL of a 1.25 µM stock primer. 
Amplification curves display how similar the duplicate samples are by 
how close together the same color curves are. As the amount of input 




Optimization of primer annealing temperatures using gradient PCR analysis 
To continue our strategy of qPCR analysis optimization, we next performed gradient 
PCR analysis to determine the optimal annealing temperatures for our qPCR primers. 
Gradient PCR analysis also allowed us to visualize our PCR products to determine if 
our primers were amplifying a band of the correct size and determine if any non-
specific products were being generated. A primer gradient was performed utilizing 
different concentrations of cDNA, as well as a gradient of temperatures (54.2, 55.2, 
57.8, 59.5, 62.7, 64.1°C). The PCR products were run on a 2% agarose gel run for 50 
minutes at 100 V. Bands did not appear for SOX5 or WWOX for 50 ng, 100 ng, and 
200 ng. Faint bands were seen at 500 ng but not at 1 µg of cDNA at the tested 
temperatures signifying that these primers are not optimally amplifying their sequence 
targets or indicating that these genes were being expressed at very low levels (Fig. 9). 
The GAPDH primers, our positive control and housekeeping gene, showed 
amplification at each of the cDNA quantities as well as at all of the tested 
temperatures. We also saw amplification for the FANCD2 primers at 100 ng, 200 ng, 
500 ng, and 1µg of cDNA at temperatures of 57.8, 59.5, 62.7, and 64.1 °C. 
 After determining that the WWOX and SOX5 primers tested were not optimally 
performing, new primer sets for both genes were ordered and tested. The new primer 
sets were tested at 200 ng and 500 ng of cDNA and temperatures of 59.4, 62.4, 64.3, 
66.2, 68.1, and 71 °C. Bands were faintly seen at 500 ng for both SOX5 and WWOX at 
temperatures of 59.4, 62.4, 64.3, 66.2, 68.1°C (Fig. 10). GAPDH was again used as 
the positive control with bands at all temperatures except for 59.4 °C for 500 ng 




500 ng of cDNA as each primer set appeared to have the brightest band at this 





































Figure 9. Primer gradients using different quantities of cDNA and 
melting temperatures. Different concentrations of cDNA (50 ng, 100 
ng, 200 ng, 500 ng, 1µg), as well as increasing melting temperatures 
(54.2, 55.2, 57.8, 59.5, 62.7, 64.1 °C), were run using a gradient PCR to 
determine the optimal melting temperature for each primer set. Products 
were run on a 2% agarose gel for 50 minutes with a 100 bp ladder and 
imaged using BioRad imager. Optimal temperature and cDNA 


























Figure 10. Optimal melting temperature determined for new primer 
sets. New primer sets for SOX5 and WWOX run on primer gradients using 
different quantities of cDNA and melting temperatures. Different 
concentrations of cDNA (200 ng, 500 ng), as well as increasing melting 
temperatures (59.4, 62.4, 64.3, 66.2, 68.1, 71.0 °C), were run using a 
gradient PCR to determine the optimal melting temperature for each 
primer set. Products were run on a 2% agarose gel for 50 minutes with a 
100 bp ladder and imaged using BioRad imager. Optimal temperature and 




Analysis of the protein expression of SOX5 following aphidicolin exposure 
To study if APH inducing replication stress affected the protein expression of SOX5, 
we analyzed via immunoblotting whole cell lysates treated with APH for 24, 48, and a 
24-hour release samples (Fig. 11a). It is known that APH induces the 
monoubiquitination of FANCD2 and FANCD2 was confirmed to be 
monoubiquitinated in this experiment as can be seen in Figure 9b showing the top 
band at the 24-, 48-, and 24-hour release samples. Monoubiquitination is confirmed by 
the top band in the FANCD2 western blot. L/S ratios which are the ratio between 
monoubiquitinated FANCD2 and unubiquitinated FANCD2 were calculated. There is 
an increase in the monoubiquitination after 48 hours of APH compared to the 24-hour 
APH sample and the release samples shows that monoubiquitination has decreased 
(Fig. 11b). We saw an increase in the protein expression in SOX5 following APH 
treatment in the immunoblots as can be seen by comparing the 24-, 48-, and 24-hour 
release samples to the no treatment sample (Fig. 11b). Tubulin was used a loading 
control. Protein bands were further analyzed using ImageJ to measure protein band 
intensities and band intensity was averaged across replicates (Fig. 11c). It can be seen 
in the fold change of protein expression graph that there was an increase in the band 
intensity further concluding that there was an increase in protein expression of SOX5 
following the APH treatment (Fig. 11c). Standard deviations can also be seen on the 
fold change expression graph displaying replicates with similar expression levels. 
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Figure 11. Effect of aphidicolin on SOX5 protein expression. a. Cartoon of 
experimental design. U2OS 3xFLAG cells were incubated in the absence (No 
Treatment; NT) or presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours 
plus 24 hours of release. b. The abundance of SOX5 and FANCD2 proteins 
present in whole-cell lysates was determined by immunoblot using anti-SOX5 
and anti-FANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody, 
serves as a loading control. c. Protein band intensities analyzed using ImageJ and 
statistical significance was determined using student’s two-tailed paired t-test. *P 




Analysis of protein expression of WWOX following aphidicolin exposure 
We also analyzed the protein expression of WWOX following APH treatment and 
determined that there was no difference between the no treatment condition and the 
aphidicolin treated (Fig. 12b). The band intensity of the 24-, 48-, and 24-hour APH 
release samples look the same as the no treatment sample (Fig. 12b). Further analysis 
of the band intensity was again done by use of ImageJ quantification. It can be seen 
that there is minor increase in the protein expression in the treated samples (Fig. 12c). 
The standard errors are also shown on the fold change expression graph and display 
replicates with similar expression levels. Bonferroni correction was applied by 














































































Figure 12. Effect of aphidicolin on WWOX protein expression. a. 
Cartoon of experimental design. U2OS 3xFLAG cells were plated at 1 
million cells/mL and incubated in the absence (No Treatment; NT) or 
presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 
hours of release. b. The abundance of WWOX and FANCD2 proteins 
present in whole-cell lysates was determined by immunoblot using anti-
WWOX and anti-FANCD2 antibodies. Tubulin, detected with an anti-
Tubulin antibody, serves as a loading control. c. Protein band intensities 
analyzed using ImageJ. *P < 0.01 and Single Factor ANOVA. 




Analysis of the impact/effect of loss of FANCD2 on SOX5 protein expression  
We then wanted to determine what the consequences of the loss of FANCD2 would 
have on SOX5 protein expression following aphidicolin treatment. We treated U2OS 
3xFLAG cells with an siFANCD2 and an siControl for 24 hours followed by 0.4 µM 
APH treatment (Fig. 13a). In comparison to the siControl samples, there are no bands 
in the lanes treated with the siFANCD2 (Fig. 13a). Results of the siControl bands 
reveal that there is an increase in protein band intensity in the 48-hour and release 
samples in comparison to the no treatment sample (Fig. 13b). In samples treated with 
an siFANCD2, there is a minor decrease in protein levels in the 24-hour and release 
sample lanes in comparison to the siFANCD2 no treatment lane (Fig. 13b). There does 
not appear to be a change in expression levels when comparing the siFANCD2 48-
hour sample to the siFANCD2 no treatment sample (Fig. 13b). Changes in expression 
levels were confirmed using ImageJ again to quantify the intensity of the protein 
bands showing the decrease in siFANCD2 samples and increase in siControl samples 
(Fig. 13c). The standard deviations can also be seen on the fold expression protein 
level graph and show that replicates had similar expression levels for each of the 
samples tested. Bonferroni correction was applied by dividing 0.05 by the number of 







































































































Figure 13. Effects on SOX5 after siRNA knockdown of FANCD2. a. 
Cartoon of siRNA experimental design. U2OS 3xFLAG cells were plated at 
175,000 cells/mL and treated with either an siControl or siFANCD2 for 24 
hours. On Day 4 U2OS were incubated in the absence (No Treatment; NT) or 
presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of 
release. b. The abundance of SOX5 and FANCD2 proteins present in whole-
cell lysates was determined by immunoblot using anti-SOX5 and anti-
FANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody, serves as 
a loading control. c. Protein band intensities analyzed using ImageJ with 
siControl shown in blue and siFANCD2 shown in orange. Protein band 
intensities analyzed using ImageJ. *P < 0.01 and Two-Factor ANOVA. 




Analysis of the impact/effect of loss of FANCD2 on WWOX protein expression  
The same siRNA treatment was also performed to test WWOX using the same 
siFANCD2 and siControl and using whole cell extracts looking at protein expression 
via immunoblotting (Fig. 14a). In contrast to SOX5, western blots displaying WWOX 
do not show an increase or decrease in protein level expression in the siControl lanes 
or the siFANCD2 lanes except for the release sample in the siFANCD2 western lanes 
(Fig. 14b). There does seem to be an increase in expression level when comparing the 
siFANCD2 release sample to the siFANCD2 no treatment sample.  
 ImageJ analysis of band intensities display a slight reduction in the expression 
of WWOX protein in the absence of FANCD2 as well as in the siControl samples, but 
it is very minor (Fig. 14c). For both the siControl and siFANCD2 samples, they 
increase initially from the no treatment to the 24-hour APH treatment and then 
decrease back down to the same level as the no treatment sample. Standard deviations 
also show that replicates were similar (Fig. 14b). Bonferroni correction was applied by 







































































































Figure 14. Effects on WWOX after siRNA knockdown of FANCD2. a. 
Cartoon of siRNA experimental design. U2OS 3xFLAG cells were plated at 
175,000 cells/mL and treated with either an siControl or siFANCD2 for 24 
hours. On Day 4 U2OS were incubated in the absence (No Treatment; NT) 
or presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 
hours of release. b. The abundance of SOX5 and FANCD2 proteins present 
in whole-cell lysates was determined by immunoblot using anti-SOX5 and 
anti-FANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody, 
serves as a loading control. c. Protein band intensities analyzed using ImageJ 
with siControl shown in blue and siFANCD2 shown in orange. *P < 0.01 





Analysis of the impact/effect of loss of FANCD2 on SOX5 gene expression  
Following the analysis of protein expression of SOX5 following an siFANCD2 
treatment and APH treatment, we wanted to observe if there were transcript changes to 
SOX5. Samples were run in triplicate and three biological samples were tested and 
averaged with GAPDH used as the control housekeeping gene. In the absence of 
FANCD2, there is an increase initially in the no treatment sample compared to the 
siControl no treatment sample. After 24 hours of APH treatment, there is an increase 
in the transcript levels for both the siControl and siFANCD2 samples. In the 48-hour 
samples, there is a decrease in the siControl in comparison to the 24-hour sample and 
is at the same level as the no treatment sample. siFANCD2 at 48 hours also decreases 
compared to the 24-hour and again at the same level as the no treatment sample (Fig. 
15). Both siControl and siFANCD2 displayed an increase in transcript levels in the 24-
hour release samples compared to the no treatment (Fig. 15). Significant differences 
were seen between the siControl no treatment and siFANCD2 no treatment (Fig. 15). 
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Figure 15. Analysis of SOX5 gene expression in U2OS cells 
incubated in the absence or presence of aphidicolin (APH). U2OS 
cells were incubated in the absence (No Treatment) or presence of 0.4 
µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release. 
Cells were also treated with either an siControl (blue bars) or an 
siFANCD2 (orange bars). Error bars represent the standard errors of the 
mean calculated from twenty-seven technical replicate measurements 
from three independent biological replicate experiments. Statistical 
significance was determined using student’s two-tailed paired t-test. *, P 




Analysis of the impact/effect of loss of FANCD2 on WWOX gene expression  
Again, following the analysis of protein expression of WWOX in the presence of an 
siFANCD2 treatment and APH treatment, we wanted to observe if there were 
transcript changes to WWOX. Samples were again run in triplicate and three biological 
samples were tested and averaged with GAPDH used as the control housekeeping 
gene. In the absence of FANCD2, there is an increase initially in the no treatment 
sample compared to the siControl no treatment sample. Post 24 hours of APH 
treatment, there is an increase in the transcript levels for the siControl sample, 
however the siFANCD2 sample has stayed level with the no treatment sample. In the 
48-hour samples, there are decreases in the both the siControl and siFANCD2 samples 
compared to the 24-hour and no treatment samples (Fig. 16). Both siControl and 
siFANCD2 displayed an increase in transcript levels in the 24-hour release samples 
compared to the untreated samples (Fig. 16). A significant difference was seen 
between the siControl no treatment and the siFANCD2 no treatment. Bonferroni 
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Figure 16. Analysis of WWOX gene expression in U2OS cells 
incubated in the absence or presence of aphidicolin (APH). U2OS 
cells were incubated in the absence (No Treatment) or presence of 0.4 
µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release. 
Cells were also treated with either an siControl (blue bars) or an 
siFANCD2 (orange bars). Error bars represent the standard errors of the 
mean calculated from twenty-seven technical replicate measurements 
from three independent biological replicate experiments. Statistical 
significance was determined using student’s two-tailed paired t-test. *, P 




RNA sequencing analysis of ACHT hTERT FANCG (FANCD2 -/-) and ACHT 
hTERT FANCD2 reveal no levels of SOX5 and low levels of WWOX 
As previously stated, FANCD2 was found to bind to and traverse large actively 
transcribed genes in U2OS 3xFLAG cells under conditions of replication stress. 
However, we wanted to see the effects of treatment with aphidicolin on telomerase 
immortalized cells lacking FANCD2 as well as telomerase immortalized cells with 
FANCD2 complemented back into the cell. A different cell line was chosen as ACHT 
hTERT cells are human FA-D2 (FANCD2-/-) telomerase-immortalized skin fibroblast 
cells with one cell line having FANCD2 complemented into the cell. By utilizing a 
patient cell line, we are able to test and observe the effects that may be more 
realistically occurring within the cells of FA patients. 
 ACHT FANCG (FANCD2-/-) cells were treated with 0.4 µM aphidicolin for 
24 and 48 hours, harvested and sent to Genewiz for RNA sequencing analysis at 150 
bp paired end sequencing at 60 million reads per sample. The analysis looked at read 
counts which are the number of times a read maps to a specific gene. SOX5 was not 
found to be expressed in the dataset and WWOX had similar read counts between cells 
with FANCD2 and cells without FANCD2 but the difference in read counts was not 
significant (Fig. 17).  
 Independent of SOX5 and WWOX, the RNA-seq dataset allowed us to analyze 
the levels of expression of all FANCD2 targets identified by ChIP-seq. In the ChIP-
seq dataset generated by Okamoto et al., FANCD2 was found to bind to approximately 
120 genes under conditions of replication stress. Therefore, we asked the question of if 




or presence of FANCD2 and in the absence or presence of replication stress. Using the 
differential analysis datasets for the no treatment samples, provided from Genewiz, it 
was found that 79 of the 120 ChIP-seq genes were expressed in the RNA-seq data. In 
the 24-hour APH samples 66 of the 120 ChIP-seq genes were expressed. Of the 79 
genes found to overlap, 26 were found to be differentially expressed with 7 being 
downregulated and 19 being upregulated (Table 7). In this data, upregulated refers to 
an increase in ACHT hTERT FANCD2’s and downregulated refers to an increase in 
ACHT hTERT FANCG’s. In the 24-hour APH treated samples, 22 of the 66 
overlapping genes were found to be differentially expressed with 7 being 
downregulated and 15 being upregulated (Table 8). Interestingly, 7 of the 26 genes 
found in the no treatment samples and 6 of the 22 genes found in the 24-hour APH 
treated samples are found to be related to autism, neurodevelopmental, psychiatric 
disorders. 
 The RNA-seq data also allowed us to observe if there were differences in gene 
ontology. Genewiz also provided a gene ontology analysis which categorized the gene 
ontology and enrichment of gene ontology. It was found that the 5th most significantly 
enriched gene sets in the 24-hour APH treated samples were nervous system 









































































24 h APH 0.4 µM
Figure 17. RNA-seq analysis reveals no significant differential 
expression in WWOX. Differential expression analysis displays the 
number of reads found per gene and if there is a significant difference 
between the ACHT hTERT +FANCD2 cells and the ACHT hTERT 
+FANCG (FANCD2 -/-) cells. Cells were incubated in the absence (no 
treatment) or presence of 0.4 µM APH. Normalized reads were averaged 
between the 4 replicates for both cell lines and the standard deviation 








Gene Name log2FoldChange P-value 
TENM4* -2.36 2.34E-15 
FAM155A -0.87 7.24E-07 
NLGN1* -0.76 2.71E-10 
PPP1CC -0.75 5.68E-04 
SRSF3 -0.65 4.56E-03 
ASTN2* -0.61 3.84E-04 
FARS2 -0.60 1.73E-03 
FRMD8 0.55 2.98E-05 
GPC6 0.56 2.74E-04 
PTPRM 0.63 1.86E-02 
NEGR1* 0.69 2.98E-05 
KIRREL3* 0.72 2.00E-03 
BTBD9 0.74 3.80E-06 
FHIT 1.01 3.50E-02 
SMYD3 1.17 4.37E-08 
ANKS1B 1.41 2.50E-02 
SPOCK1 1.43 8.51E-25 
NTM 1.71 7.75E-11 
FGF12 1.71 1.65E-03 
LMCD1 1.79 2.46E-22 
CDH4 2.42 3.62E-06 
PLCB1* 2.53 4.38E-15 
NCAM2* 2.94 5.40E-46 
PAPPA2 4.52 4.69E-27 
CTNND2 7.59 4.07E-12 
PTPRD 9.44 2.24E-19 
 
 
Table 7. RNA sequencing heat map of no treatment samples. Of the top 120 genes 
from the Okamoto et al., 2018 ChIP-seq data, we observed that 27 genes from our 
RNA seq analysis using ACHT hTERT +FANCD2 and ACHT hTERT +FANCG 
were found to have log2foldchanges either <-0.5 or >0.5 and a P-value <0.05. Genes 










Gene Name log2FoldChange P-value 
TENM4* -3.19 3.31E-56 
FAM155A -0.98 8.66E-24 
LARGE1 -0.86 1.49E-26 
FAT3 -0.71 4.84E-08 
MDGA1* -0.57 4.53E-08 
MAGI2 -0.55 2.91E-08 
AFF2 -0.53 7.74E-05 
GPC6 0.68 3.18E-15 
LSAMP* 0.76 1.80E-11 
INPP4B 0.84 1.38E-17 
THSD7B 0.89 6.53E-03 
PRKN 0.97 1.57E-02 
SPOCK1 0.99 1.54E-68 
NEGR1* 1.03 1.73E-20 
SMYD3 1.32 2.68E-23 
CDH4 1.41 2.00E-05 
ANKS1B 2.64 6.75E-07 
NCAM2* 2.81 3.27E-95 
PLCB1* 3.27 1.51E-31 
FGF12 3.84 8.69E-07 
PAPPA2 4.17 3.13E-11 
PTPRD 7.99 4.41E-21 
 
 
Table 8. RNA sequencing heat map of 24 h APH samples. Of the top 120 genes 
from the Okamoto et al., 2018 ChIP-seq data, we observed that 17 genes from our 
RNA seq analysis using ACHT hTERT +FANCD2 and ACHT hTERT +FANCG 
were found to have log2foldchanges either <-0.5 or >0.5 and a P-value <0.05. Genes 












 The protection and tight regulation of our genome is dependent upon the 
coordination of several DNA repair pathways, including the FA pathway, to ensure the 
timely repair of DNA damage. FANCD2, one of the key proteins in the FA pathway, 
has recently been seen to bind to and traverse large actively transcribed genes under 
conditions of replication stress (Okamoto et al., 2018). We sought to answer the 
question of why is FANCD2 binding to these genes and if by doing so it has another 
role in addition to the FA pathway as a potential regulator of transcription. 
 We used a candidate gene approach targeting SOX5 and WWOX which are 
found in the top 10 genes FANCD2 was seen to bind to in the Okamoto ChIP-seq 
dataset (Okamoto et al., 2018). SOX5 was chosen as it is a transcription factor that has 
been seen to be involved in breast cancer regulation by the transactivation of EZH2 
(Sun et al., 2019). It is also involved in the regulation of embryonic development as 
well as the determination of cell fate (Pei et al., 2014). Choosing a gene involved in 
breast cancer regulation is relevant as the FA pathway primarily monitors and repairs 
sites of DNA damage that could otherwise lead to the development of bone marrow 
failure, leukemia, or premature cancers (Alter et al., 2018). WWOX was also chosen as 
it is a member of short-chain dehydrogenases and found to span the common fragile 
site FRA16D (Driouch et al., 2002). It has also been seen that WWOX may play a role 




ATM. Common fragile sites have an increased risk of being preferential targets of 
genomic instability such as chromosomal breaks in response to replicative stress (Abu-
Odeh et al., 2014) 
 In this study, we observed that there is an increase in the protein levels of 
SOX5 under conditions of replication stress and that this increase is significant in the 
24-hour APH treatment compared to the no treatment sample. We also did test to see 
if there was a difference in a 24-hour no treatment sample and 48-hour no treatment 
sample for both SOX5 and WWOX and did not see differences in the protein levels 
(Fig. 18). However, using qPCR to analyze the transcript levels of SOX5, we did not 
see a significant difference when comparing the APH treated samples to the no 
treatment control sample. There was also little change in WWOX both in protein and 
transcript levels while FANCD2 was present and under the same conditions of 
replication stress using APH. It was also found that to observe transcript levels, a large 
quantity of cDNA (500 ng/µL) was needed for qPCR to observe crossing points that 
were within the accepted analysis range. A possible reason for the limited changes in 
the protein levels and overall low abundance of gene expression could be that these 
two genes are just lowly expressed, and the proteins are very stable in U2OS 3xFLAG 
cells. It could also be that the proteins for these genes are very stable and therefore the 
mRNA is not always needed/necessary, so it is in low abundance. It should also be 
noted that there is the possibility that these genes are so big and as seen in the 
Okamoto et al., 2018 paper that it can take multiple cell cycles for these genes to be 
transcribed, potentially causing replication-transcription conflicts. It would be 




determine how long each of these can be seen in a cell. If they can be seen for a longer 
duration of time, it would support the idea that both proteins are stable and therefore 
less mRNA would be needed.  
 Further analysis using an siFANCD2 to knockdown FANCD2 expression in 
U2OS 3xFLAG cells as well as aphidicolin treatment, resulted in no difference in 
protein expression levels regardless of FANCD2 presence for WWOX. This 
experiment was performed to determine the impact the absence of FANCD2 could 
have had on both SOX5 and WWOX genes and proteins. Protein expression for SOX5 
was seen to increase under APH conditions in the presence of FANCD2 while without 
FANCD2, there was slight decrease in the recovery sample, but the decrease was not 
significant. Interestingly, our experiments indicate that both SOX5 and WWOX 
transcript levels are increased in the absence of the FANCD2 protein. These results 
suggest that in the absence of FANCD2, WWOX and SOX5 transcript levels are 
increasing suggesting that FANCD2 may be monitoring their transcription and without 
it, the genes are less controlled. If the transcription of WWOX and SOX5 is less 
controlled, they could be transcribed even when they are not necessarily needed. As 
these genes are prone to CNVs and WWOX overlaps with FRA16D, the uncontrolled 
transcription of them could lead to an increase in genome instability and more 
susceptibility to cancer.  
As the differences seen in our results are minor, with some of the differences 
not being significant, it brought us to the question of is FANCD2 regulating 
transcription and if not, what is it doing at these two gene sites? It could be that 




of the DNA at sites that are more prone to DNA damage. It has been previously seen 
that in the absence of FANCD2, replication forks stall within the AT-rich fragility 
core of the FRA16D CFS and this can lead to the dormant origin activation 
(Madireddy et al., 2016). It has also been previously seen that under conditions of 
replication stress, FANCD2 is able to promote DNA replication (Lossaint et al., 2013).  
 It has also been seen that FANCD2 may play a role in the regulation of R-
loops. R-loops, which are DNA: RNA hybrids are hazards to the genome and can 
increase the probability of disruption of chromatin organization. The displaced ssDNA 
in R-loops also poses a threat to the stability of the genome as ssDNA is more prone to 
attracting nucleases (Sollier & Cimprich, 2015). However, R-loops can also be non-
hazardous in the genome as they are required for immunoglobulin class switching 
(García-Muse & Aguilera, 2016). Previously, Okamoto et al., 2018 also saw that 
FANCD2 accumulates at large transcribed genes and that its accumulation may 
depend on the formation of R-loops which can be induced by transcription-replication 
collisions during mild replication stress. It would be interesting to determine if 
FANCD2 is proximal to where these events are occurring and comparing the same 
areas in the absence of FANCD2 under mild replication stress. 
 To study the role of FANCD2 in transcriptional regulation at a genome-wide 
level, we also performed RNA-seq analysis using ACHT hTERT FANCD2 and 
ACHT hTERT FANCG (FANCD2-/-) cells. We chose to use these cells because they 
are FA patient-derived skin fibroblasts unlike U2OS cells, which are derived from an 
osteosarcoma. ACHT cells therefore more closely resemble those of an FA patient. 




the other 120 top gene hits from the Okamoto et al., paper. We observed that SOX5 
was not expressed, and a small expression of WWOX was seen but with no significant 
difference with/without the presence of FANCD2 (Fig. 17).  
 Upon further analysis of our RNA sequencing data, we found that of the 120 
genes in the Okamoto et al., 2018 data set, 79 of the ChIP-seq genes were expressed in 
the RNA-seq data in the no treatment sample and 66 genes in the 24-hour APH treated 
samples. Of those 79 genes found to overlap, 26 genes were found to have log2fold 
changes less than -0.05 or greater than 0.05 in the no treatment sample and 22 in the 
24-hour APH treated samples (Tables 7 & 8). Of the 26 genes we also saw that 7 were 
downregulated meaning that there is an increase in the ACHT hTERT FANCG’s and 
19 were upregulated meaning that there is an increase in the ACHT hTERT FANCD2 
samples (Table 9). In the APH treated samples, it was found that 7 genes were being 
downregulated and 15 were upregulated (Table 10). Interestingly, 7 of the 26 in the no 
treatment samples and 6 of the 22 genes found in the APH treated samples are found 
to be related to autism, neurodevelopmental, psychiatric disorders. These findings and 
differences seen in the RNA sequencing data support the notion that FANCD2 could 
be playing a role in the transcriptional regulation of some genes.  
Furthermore, it was found that a portion of the significantly differentially expressed 
genes are related to nervous system development or nervous system conditions, 
therefore suggesting that FANCD2 could also be contributing to the regulation of 
neuronal derived genes.  
 We also input the genes found to have significant differences in gene 




for both the no treatment samples and the APH treated samples (Figs. 19 & 20). If 
there is a line between nodes, this indicates that there is an interaction between the 
proteins. If there is no line, there is no interaction. The color of the line also represents 
different associations with blue being that it is a known interaction from a curated 
database, pink is experimentally determined, green is a gene neighborhood, red is gene 
fusions, blue is gene co-occurrence, yellow is textmining, black is co-expression, and 
purple is protein homology. Many of the proteins displaying an interaction are 
associated with neuronal development such as the link between CTNND2, PTPRD, 
ASTN2, and NLGN1 in the no treatment samples as seen in Fig. 18. All four of these 
proteins play a role in neuronal development. Looking at the 24-hour APH samples it 
can also be seen that there is a link between LSAMP, NEGR1, and MDGA1 which are 
also related to neuronal functions (Fig. 20).  
This analysis using the STRING database and our RNA sequencing data 
reveals that there are proteins that have a significant difference in gene expression 
between ACHT hTERT +FANCD2 and ACHT hTERT +FANCG samples that are 
directly linked to neurological development functions. The STRING database is able 
to integrate all known and predicted associations between proteins including but 
physical and functional interactions. This is interesting because it further proposes the 
possibility that FANCD2 has another role distinct from ICL repair in the FA pathway 
and that the role could involve regulating neuronal development.  
It was also observed that among the top differentially expressed genes 
clustered by gene ontology, nervous system development was seen as the 5th most 




analysis aims to identify the biological processes, cellular locations, and molecular 
functions that have been impacted in the condition studied. This analysis is able to 
reduce the complexity and instead highlight the biological processes in the genome-
wide expression studied.  Identifying nervous system development as one of the 
systems affected in this study which utilized two cell lines with one lacking FANCD2 
additionally supports a hypothesis of FANCD2 assisting with neuronal development 
and having another purpose apart from the FA pathway.  
 
Future Experiments 
We have made significant progress determining the consequences of replication stress 
in the presence and absence of FANCD2 for WWOX and SOX5 and if FANCD2 
could be involved in the transcriptional regulation of these two genes. However, these 
were only two of the 120 genes that FANCD2 was found to bind to in the ChIP-seq 
data (Okamoto et al., 2018). Here, we will propose several experiments to further 
answer our question of why FANCD2 is binding and traversing large actively 
transcribed genes under replication stress conditions. 
 We would further like to determine whether FANCD2 is also involved in the 
regulation of R-loops as these as previously stated, also pose a threat to genomic 
stability. The S9.6 antibody can be used to detect the presence of R-loops and it has 
been previously seen that the members of the FA pathway (BRCA2/FANCD1) 
accumulate at R-loops (García-Rubio et al., 2015). Since the FA pathway is involved 
in the repair of interstrand crosslinks which block replication fork progression, this 




loops may be a contributor to genomic instability in FA cells (Schwab et al., 2015). 
Schwab et al., 2015 also found that in cells with downregulated FANCD2, there was a 
significant increase in asymmetric sister forks compared to their control cells which 
suggests that that there is a deviation from the normal replication program. This also 
suggests that FANCD2 may play a role in the regulation of replication. A previous 
study also found that in cells deficient in FANCD2 and FANCA, there was an increase 
in the number of R-loops suggesting that these two proteins play a role in R-loop 
regulation (García-Rubio et al., 2015). It has also been previously found that the 
FANCD2: FANCI heterodimer (ID2) preferentially binds ssRNA but not RNA: DNA 
hybrids making it seem as though ID2 binds to the ssRNA that is displaced in R-loops 
(Liang et al., 2019).  
 We would also like to further investigate other genes, separate from the 
Okamoto dataset, that are found in our RNA sequencing data and have normalized 
read counts that are significantly different. In the no treatment conditions, we have 
examined the data and created a list of potential gene targets from different cell 
pathways and families such as retinaldehyde dehydrogenases. Of the genes found to 
have significant differences in normalized read counts in the RNA sequencing data, 
we will perform western blots and qPCR on a subset of these genes to further confirm 
the differences seen in the RNA sequencing data. We are also planning to perform 
ChIP-seq on the ACHT hTERT +FANCD2 and ACHT hTERT +FANCG under APH 
conditions to be able to compare to the U2OS 3xFLAG ChIP-seq data. This will be 




that FANCD2 was found to bind to in the U2OS 3xFLAG cells are similar or different 
in ACHTs.  
 We would also like to use a neurological stem cell line and using our 
siFANCD2, determine the consequences of the absence of FANCD2 on a number of 
genes found in the RNA sequencing data. We found in our RNA sequencing data, that 
the development of neurological systems was found to be fifth in differentially 
expressed gene ontology and of the 22 genes found to overlap with the ChIP 
sequencing data and our RNA sequencing data under APH conditions, 6 of the 22 
gene were found to be related with autism, neurodevelopmental, or psychiatric 
disorders (Table 8). Using the neurological stem cell line would help us understand 
more of whether FANCD2 is an integral part in maintaining neurological functions. 
We would use qPCR as well as western blotting to detect if there are differences with 



























Figure 18. U2OS 3xFLAG cells grown for either 24 hours or 48 
hours with no treatment (NT) added. Abundance of SOX5 and 
WWOX proteins present in whole-cell lysates was determined by 
immunoblot using an anti-SOX5 and anti-WWOX antibodies. Tubulin, 















Figure 19. RNA sequencing reveals potential link between FANCD2 
and neurological development in no treatment samples. Cells were 
harvested, flash frozen using liquid nitrogen and sent to Genewiz for 
RNA sequencing analysis at 150 bp paired end sequencing at 60 million 
reads per sample. Using the differential analysis datasets for the no 
treatment samples provided from Genewiz, it was found that 26 of the 
120 Okamoto et al., 2018 ChIP-seq genes FANCD2 was found to bind to 
overlap with the RNA seq data for the no treatment samples. Of the 26 
genes, 7 of them are found to be related with autism, 
neurodevelopmental, or psychiatric disorders. The 26 genes were input 
to STRING database to see if they connect to one another. The color of 
the line also represents different associations with blue being that it is a 
known interaction from a curated database, pink is experimentally 
determined, green is a gene neighborhood, red is gene fusions, blue is 
gene co-occurrence, yellow is textmining, black is co-expression, and 



















Figure 20. RNA sequencing reveals potential link between FANCD2 
and neurological development in aphidicolin treated samples. Cells 
were harvested, flash frozen using liquid nitrogen and sent to Genewiz 
for RNA sequencing analysis at 150 bp paired end sequencing at 60 
million reads per sample. Using the differential analysis datasets for the 
24-hour APH samples provided from Genewiz, it was found that 22 of 
the 120 Okamoto et al., 2018 ChIP-seq genes FANCD2 was found to 
bind to overlap with the RNA seq data for the no treatment samples. Of 
the 22 genes, 6 of them are found to be related with autism, 
neurodevelopmental, or psychiatric disorders. The 22 genes were input 
to STRING database to observe the relationship between one another. 
The color of the line also represents different associations with blue 
being that it is a known interaction from a curated database, pink is 
experimentally determined, green is a gene neighborhood, red is gene 
fusions, blue is gene co-occurrence, yellow is textmining, black is co-















Figure 21. RNA-seq data displaying 24-hour aphidicolin (APH) 
differentially expressed genes categorized by gene ontology. ACHT 
hTERT FANCG (FANCD2 -/-) cells and ACHT hTERT FANCD2 were 
incubated in the absence or presence of 0.4 µM aphidicolin (APH) for 
24 and 48 hours in T-75 flasks. Cells were harvested, flash frozen using 
liquid nitrogen and sent to Genewiz for RNA sequencing analysis at 150 
bp paired end sequencing at 60 million reads per sample. Genewiz 
analysis provided a differentially expressed genes by gene ontology 
table in which it was found that the 5th most differentially expressed was 
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